MarketInOut Stock Screener Log In | Sign Up
 

Precipio Inc

NASDAQ • Healthcare • Diagnostics & Research • Quote as of 10/23/2026
Precipio Inc stock price and volume chart

Company Profile

IndustryDiagnostics & Research
SectorHealthcare
ExchangeNASDAQ
Market Capitalization35.82 mln
Float1.57 mln
Earnings Date11/13/2026

Piotroski F-Score

6 / 9
Solid

Beneish M-Score

-2.56
Likely reliable

Relative Strength

19 / 100
Significantly lagging

Debt / Equity

0.24
Very low leverage

Pre-Tax Margin

-4%
Marginally loss-making

ROE

-8.74
Negative

Business Description

Precipio is a Connecticut-based company specializing in cancer diagnostics, offering blood cancer testing services alongside its own line of laboratory tools and genetic testing panels. Its products help medical professionals identify cancer at the cellular and genetic level with greater accuracy. The company also partners with pharmaceutical and biotech firms to support research through biomarker testing and clinical project work.

Key Fundamentals

EPS-0.64
ROE-8.74
RPS15.60
ROIC-8.98
ROA-5.87
Interest Cover64.42
EBITDA, mln0.67
EV / EBITDA63.68
EV / EBIT-36.76
Revenue, mln27.20
EV / Revenue1.58

Quote Details

Last 20.01
Change -0.6 (-2.91%)
Open 20.57
Volume 11,193
Turnover 223,972
Average Volume 47,663

Financial Ratios

Pre-Tax Profit Margin-4
Leverage Ratio1.44
Current Ratio1.77
Price / Book2.87
Price / Tangible Book9.83
Price / Cash Flow32.51
Price / Free Cash Flow53.94
Debt / Equity0.24
Price / Sales1.54

Financial Strength

Altman Z-Score-1.75
Piotroski F-Score 6 / 9
Beneish M-Score-2.56
Short Ratio0.47
Short % of Float4.22

Price Performance & Relative Strength

Period Price Performance Relative Strength
1 Week -6.41% 14 / 100   
1 Month -18.23% 20 / 100   
2 Months -14.49% 27 / 100   
6 Months -28.54% 22 / 100   
1 Year -5.03% 41 / 100   



Disclaimer - Privacy Policy - Terms Of Service - Cookie Use Policy - FAQ - Blog